Haloperidol and lithium carbonate treatment did not influence serum immunoglobulin levels in schizophrenic and affective patients

B. Spivak*, M. Radwan, P. Bartur, J. Brandon, S. Tyano, A. Weizman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Serum immunoglobulin levels were studied in 153 psychiatric patients (87 schizophrenic, 48 bipolar and 18 unipolar patients), and 35 healthy controls. Psychotropic treatments (haloperidol in the schizophrenic patients and lithium in the bipolar affective patients) did not alter serum immunoglobulin levels. Decreased mean IgM serum level was detected in the major affective patients (unipolar and bipolar) compared with normal controls. Nonspecific environmental, infectious, autoimmune and emotional factors that can play a role in the alterations obtained in psychiatric patients are discussed.

Original languageEnglish
Pages (from-to)225-228
Number of pages4
JournalActa Psychiatrica Scandinavica
Volume84
Issue number3
DOIs
StatePublished - Sep 1991

Keywords

  • affective disorder
  • haloperidol
  • immunoglobulin
  • lithium
  • schizophrenia

Fingerprint

Dive into the research topics of 'Haloperidol and lithium carbonate treatment did not influence serum immunoglobulin levels in schizophrenic and affective patients'. Together they form a unique fingerprint.

Cite this